In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Reliant Pharmaceuticals attempts again to go public; withdrawn

Executive Summary

Reliant Pharmaceuticals (cardiovascular and gastrointestinal therapeutics) has withdrawn its second filing for an IPO because it is being acquired by GlaxoSmithKline. The company originally planned to go public in May 2005, but withdrew the $300mm offering six months later citing market conditions.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register